Amylyx Pharmaceuticals, Inc. revenue breakdown overview

Amylyx Pharmaceuticals, Inc. revenue for the last year amounted to 87.37 M USD, the most of which — 87.37 M USD — came from its highest performing source at the moment, Relyvrio (Sodium Phenylbutyrate and Taurursodiol), the year earlier bringing 380.79 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Amylyx Pharmaceuticals, Inc. 87.37 M USD, and the year before that — 380.79 M USD.